In the traditional joint models of a longitudinal and time-to-event outcome, a linear mixed model assuming normal random errors is used to model the longitudinal process. However, in many circumstances, the normality assumption is violated and the linear mixed model is not an appropriate sub-model in the joint models. In addition, as the linear mixed model models the conditional mean of the longitudinal outcome, it is not appropriate if clinical interest lies in making inference or prediction on median, lower, or upper ends of the longitudinal process. To this end, quantile regression provides a flexible, distribution-free way to study covariate effects at different quantiles of the longitudinal outcome and it is robust not only to deviation from normality, but also to outlying observations. In this article, we present and advocate the linear quantile mixed model for the longitudinal process in the joint models framework. Our development is motivated by a large prospective study of Huntington's disease where primary clinical interest is in utilizing longitudinal motor scores and other early covariates to predict the risk of developing Huntington's disease. We develop a Bayesian method based on the location-scale representation of the asymmetric Laplace distribution, assess its performance through an extensive simulation study, and demonstrate how this linear quantile mixed model-based joint models approach can be used for making subject-specific dynamic predictions of survival probability.
Introduction
Joint models (JM) of longitudinal and time-to-event data have been well developed in the literature as they are highly applicable in the settings of longitudinal data analysis with event-related terminal events (e.g. dropout or death which is related to the longitudinal process), or of survival analysis with time-dependent covariates measured with error.
1,2 JM have been extensively studied in recent years and an excellent review is provided by Tsiatis and Davidian. 3 Within the traditional JM framework, a linear mixed model (LMM) is used to model the longitudinal continuous outcome. To account for within-subject correlation, measurements from the same individual share random effects and random errors are assumed to be normally distributed. 4 However, if normality assumption of the random errors is violated (even after applying various outcome transformations), a LMM is not appropriate. Further, a LMM models covariate effects on the conditional mean of the longitudinal outcome. However, in many clinical studies, it is of interest to make inference or prediction on median, lower, or higher quantiles of the longitudinal outcome. For example, in a study of the impact of various health factors on low birth weight, which is closely associated with infant mortality and development of chronic diseases, researchers fit quantile regression (QR) models and find several covariates with much larger disparity on lower birth weight compared with that on the mean birth weight. 5 Thus, QR may serve as an alternative to conditional mean regression when the aforementioned limitations are present, or when the subject matter dictates.
In contrast to mean regression models such as LMM, original QR models offer a flexible framework that relaxes the distributional assumption, and provides a way to study covariate effects on various quantiles of the outcome. 6 QR has attracted much attention since the seminal work of Koenker and Bassett Jr, 7 and extensions for longitudinal data have been explored by many authors. [8] [9] [10] [11] Recently, Farcomeni and Viviani 12 first incorporated a linear quantile mixed model (LQMM) into a JM for longitudinal and survival processes, for which they utilized a Monte Carlo Expectation Maximization (MCEM) algorithm for parameter estimation.
Our work is motivated by the Neurobiological Predictors of Huntington's Disease (HD) study (PREDICT-HD; ClinicalTrials.gov number NCT00051324), a prospective observational study (n ¼ 1078) designed to detect early neurobiological predictors of HD. A total of 40 longitudinal biomarkers were measured during the study followup of 12 years, where the outcome of interest was time to motor diagnosis of HD (referred to as HD onset). As the primary focus of this study was to measure the association between longitudinal biomarkers and risk of HD onset, the clinical question lends itself to a joint modeling approach. The top panel of Figure 1 displays the scatter plot and the density plot (right margin of top panel, based on kernel density estimate from the observed data 13 ) of total motor score (TMS), a commonly used rating criteria of body motion abilities based on the Unified Huntington Disease Rating Scale (UHDRS). The top panel suggests that TMS increases (deteriorates) as time progresses. The bottom panel of Figure 1 displays the mean TMS values over time for individuals with follow-up time less than 48 months (solid line), 48-72 months (dotted line), and more than 72 months (slashed line). It indicates that individuals with shorter follow-up tend to have higher TMS values (worse mobility). Because individuals with higher TMS are at greater risk of developing HD, it is of particular interest to explore the risk factors' effects and disease progression on the higher tail of the TMS as opposed to the conditional mean of it.
Moreover, we are specifically interested in estimating the risk of developing HD for those individuals who are still free of the disease. To this end, the JM framework offers a novel way of making such personalized dynamic predictions of future event-free probability. 14, 15 A key feature of these dynamic predictions frameworks is that the predictive measures can be dynamically updated as additional longitudinal measurements from the target individual become available, providing instantaneous risk assessment. To make dynamic predictions in the current context, we first build the quantile regression joint model (QRJM) consisting of a LQMM for the longitudinal process and a Cox proportional hazard model (PHM) for the time to HD onset process and then draw Bayesian inference, based on a large study population. Next, conditioning on an individual's longitudinal biomarker trajectory information, we make prediction of his/her future HD-free probability by sampling from the posterior distributions of the fixed effects and of the subject-specific random effects. When new longitudinal measurements are available, we dynamically update the his/her HD-free probability. Our work is different from Farcomeni and Viviani 12 in the following: (1) we consider a full Bayesian QRJM for statistical inference while they used a MCEM algorithm; (2) more importantly, by taking advantage of the posterior distributions of model parameters and subject-specific random effects, we develop a dynamic predictions procedure for future event-free probability under the proposed QRJM.
The rest of this article proceeds as follows. In Section 2, we give details of the QRJM and statistical methods used for inference and dynamic predictions. In Section 3, we present two simulation studies to validate the proposed methods. In Section 4, we apply the proposed methods to the motivating PREDICT-HD study. We conclude the article with a discussion in Section 5.
Methods 2.1 Bayesian linear quantile mixed model
Let Y i ðt ij Þ be the longitudinal outcome for individual i measured at time t ij where i ¼ 1, . . . , N and j ¼ 1, . . . , n i . Consider the linear mixed effects model
where X i ðtÞ is a pÀdimensional covariates, b is the corresponding fixed effect vector, Z i ðtÞ is a kÀ dimensional covariates, and u i is the corresponding multivariate normal random effects vector.
A linear quantile mixed model (LQMM) assumes that the conditional quantile of the outcome is a linear function of the covariates
where the th quantile of a random variable Y is defined as
The quantile regression estimates can be obtained by minimizing the following loss function, b b ¼ arg min b2R
, where ðÁÞ is defined as ðYÞ ¼ Yð À IðY 5 0ÞÞ. In quantile regression, parameter estimators are functions of the quantile. So parameter b is a function of quantile , as denoted by the subscript . The random effects vector u i is assumed to follow multivariate normal distribution with mean 0 (irrespective of ) and quantile-specific covariance matrix D , i.e. u i $ MVNð0, D Þ.
As discussed in Koenker and Machado 16 and Yu and Moyeed, 17 the above minimization problem can be rephrased as a maximum-likelihood problem by assuming that the random error " i ðtÞ in equation (1) follows an asymmetric Laplace distribution (ALD), denoted by ALDð0, , Þ with location parameter equal to 0, scale parameter 4 0 and skewness parameter 2 ð0, 1Þ. ALDð0, , Þ is skewed to left when 4 0:5, and skewed to right when 5 0:5. When ¼ 0:5, ALD reduces to the symmetric Laplace distribution. To visualize this, Web Figure S1 displays the density functions of a standard normal distribution, a symmetric Laplace distribution, and two ALDs with ¼ 0:75 and ¼ 0:25, respectively. Adopting the ALD, the LQMM in equation (2) 
Linear programming algorithms can be applied to obtain parameter estimates under the frequentist framework. However, to develop a Bayesian sampling algorithm for model inference, we utilize a location-scale mixture representation of the ALD, 18 which is a functional form with a mixture of common distributions. Under this parameterization, the random error is represented as " i ðtÞ ¼ As discussed in Yu and Moyeed, 17 irrespective of the actual distribution of the data, Bayesian quantile regression using ALD distribution works quite well and the performance is quite robust and satisfactory.
Joint models using longitudinal quantile regression
We then extend the regular joint models (consisting of a linear mixed sub-model for the longitudinal process and a Cox PHM sub-model for the survival process, referred to as LMJM) by replacing the linear mixed sub-model with an LQMM as in equation (3). Let T i ¼ minðT 
where the first sub-model is the LQMM introduced in Section 2.1, in which X i ðtÞ are the fixed effect covariates and Z i ðtÞ are the covariates associated with kÀ dimensional random effects u i . The second sub-model takes the format of PHM where h 0 ðÁÞ is the baseline hazard function and W i are the time-independent qÀ dimensional fixed effect covariates. These two sub-models are linked by incorporating m i ðtÞ (the true underlying longitudinal measurement at the th quantile measured at time t) in the time-to-event process. The association parameter quantifies the strength of association between m i ðtÞ and the event hazard at the same time point, e.g. a positive indicates that the hazard rate will be expð Þ times higher with a unit increase in the th conditional quantile of the longitudinal outcome. Further extension of the JM in the functional form of the two processes is also possible, as discussed in Rizopoulos et al. 19 In the proposed QRJM (equation (5)), all parameters are functions of quantile . Thus, by choosing different quantiles, one can conduct a comprehensive analysis of the relationship between the outcome and the covariates. Depending on the research aims, we can take different strategies to utilize the flexibility of the QRJM. For example, to conduct a study over the entire conditional distribution of the longitudinal outcome, we can fit the QRJM through a set of pre-selected quantiles, collect and compare the resulting parameter estimations. Less varying values in the parameter estimates indicate a relatively stable covariate effect on the outcome, and vice versa. On the other hand, the interest may lie only in assessing the effect on some pre-specified quantiles (median, lower or higher quantile) of the longitudinal outcome and its association with the time-to-event process.
The survival sub-model
For individual i, the likelihood function for the survival data is
where hðT i jM (5) and SðÁÞ is the survival function, and
For the baseline hazard h 0 ðtÞ, a parametric form such as exponential model can be used or it can be left unspecified. An unspecified baseline hazard function can be estimated using a Nelson-Aalen type estimator. 20, 21 The estimator is a result of the score equation for h 0 ðtÞ, which can then be profiled out after being plugged into the likelihood function for unknown parameters. In this paper we focus on the parametric specification, specifically, the piecewise-constant baseline hazard function, based on which a closed-form survival function can be derived for each time interval. Although all parameters in the proposed QRJM are quantile dependent, for notational simplicity and without ambiguity, we omit the subscript from all parameters in the following sections (e.g. h stands for h for all quantile-based parameters).
Complete likelihood function and Bayesian inference
For individual i, the complete joint likelihood of the longitudinal and survival data can be written as
where vector h represents all the parameters in equation (7), (6), and D is a k Â k covariance matrix of the multivariate normal random effects distribution.
Parameter estimation can be made using Monte Carlo EM (MCEM) algorithm, in which random effects are treated as missing data. 12 However, we take advantage of the location-scale mixture representation of the ALD described in Section 2.1 and propose a full Bayesian inference approach via Markov Chain Monte Carlo (MCMC) for parameter estimation and personalized dynamic predictions. Given the complete likelihood in equation (7) and by Bayes theorem, the posterior distributions of the model parameters are given by
where
. . , N and f ðhÞ ¼ ðbÞðÞðÞðÞðDÞ is the product of the prior distributions. We adopt the following prior distributions: b $ N p ð0, 10 3 IÞ, $ N q ð0, 10 3 IÞ, $ N ð0, 10 3 Þ, $ IGð10 À3 , 10 À3 Þ, D À1 $ WishartðI, k þ 1Þ: These prior distributions are chosen so that they provide weak prior information. As a sensitivity analysis, we have investigated other selections of vague prior distributions with various hyper-parameters and have obtained very similar results. In the simulation studies, we have also reparameterized the covariance matrix D using the Cholesky decomposition and imposed vague prior distributions on every entry of the lower triangular matrix. We have obtained results (not shown) consistent with the current ones using Wishart prior distribution.
The advantages of using a full Bayesian approach include that the uncertainty of the parameter estimates is fully captured in the posterior distributions and no asymptotic theory is needed to derive the standard error. The full Bayesian approach provides a straightforward framework to make subject-specific prediction of survival probability using the posterior samples of the parameters and of the posterior predictive distributions for the random effects. Moreover, the proposed QRJM can be readily implemented in JAGS software 22 and the codes have been posted at the Web Supplement to facilitate easy reading and implementation of the proposed QRJM model.
Predictions of survival probability
Upon fitting the QRJM to a training dataset with N individuals, we can make prediction of survival probability for a new individual based on a set of his or her historical longitudinal measurements (denoted by Y i ðtÞ) as well as other covariates information. Given that the individual is event-free up to the censoring time t, the conditional survival probability up to time s ¼ t þ Át (Át 4 0), where Át the prediction time interval is denoted as p i ðsjtÞ ¼ PrðT
; hÞ, which can be further elaborated as follow PrðT To estimate equation (9), we can use the proposed Bayesian sampling algorithm in Section 2.4 to calculate the posterior mean of the prediction E hjD N ½ p i ðsjtÞ and
. . , Ng denotes the training data of size N and the first part of the equation is given in equation (9) . A Monte Carlo (MC) estimate of p i ðsjtÞ can be obtained using the following procedure: In above algorithm, P is the total number of post-burnin MC iterations, f ðhjD N Þ is the posterior distributions of h given in equation (8) . When an individual does not experience any event and is followed to a further time t 0 (t 0 4 t), the posterior samples of u i are then drawn from f ðu i jT Ã i 4 t 0 , Y i ðt 0 Þ, h ð pÞ Þ to reflect the update in data. By following this procedure, the predictions of event-free probability are dynamically updated with new data. The samples drawn from the posterior distribution of the random effects u i are obtained from the MCMC iterations if the individual is from the training dataset. For a new individual who is not in the training dataset, we can use the inference results to run additional MCMC iterations to obtain samples for the new individual's random effects u i and the rest of the algorithm follows. Because each individual only has a few random effects (two in our current model) to estimate, a short MCMC (e.g. with 200 iterations) should be sufficient for convergence. 15 The uncertainty of the predictions is represented in the sample variance.
Predictive performance from different models is assessed from two perspectives, calibration (how close the predicted survival probabilities are to the true values) and discrimination (how well the models discriminate between individuals who had the event from those who did not). In the simulation studies where the true survival probabilities are available, we calculate the mean squared error (MSE) of the predicted survival probabilities against the true simulated probabilities. In both simulation and data application, time-dependent receiver operating characteristic (ROC) curve method proposed by Heagerty et al. 23 is used to assess a model's discriminative ability at different prediction time points by calculating the area under the ROC curve (AUC). The nearest neighbor estimator (NNE), instead of the Kaplan-Meier (KM) estimator, is chosen because NNE is more robust against the marker-dependent censoring process and the resulting ROC curve is guaranteed to be monotonic. Higher value in AUC indicates better discriminative ability.
Simulation studies
We conduct two simulation studies to validate the proposed QRJM. In the first simulation study, we assess the performance of the proposed Bayesian method in terms of bias and precision of the parameter estimates. In the second simulation study, we assess the predicted survival probability by comparing with the ''gold standard'' calculated based on the true parameters and the simulated values of the random effects. In addition, we compare the true time-dependent AUCs with those generated from model predictions.
Simulation Study I: inferential performance
In this simulation study, we consider different simulation scenarios where the random errors are generated from either a standard normal distribution or ALD distributions at different quantile . The simulated data are then fitted using our proposed QRJM (assuming ALD for the random errors) as well as the LMJM (assuming normality for the random errors).
We let the covariate vectors in Model (5) be X i ðtÞ ¼ ð1, x i1 , x i2 Á tÞ > , Z i ðtÞ ¼ ð1, tÞ > , and W i ¼ ðw i1 , w i2 Þ > with covariates x i1 , x i2 , w i1 and w i2 being generated from independent standard normal distributions. We simulate the random effects, u i , from a bivariate normal distribution with mean vector 0, and both standard deviations equal to 0.3 and correlation coefficient equals to 0.16.
To simulate the survival time, we choose constant baseline hazard. The survival function with time-dependent covariates takes the form of Sðtju i , X i ðtÞ, Z i ðtÞ,
. We obtain event time T i by inverting the survival function after generating n random values from the standard uniform distribution. The censoring time C i is simulated from Betað4, 1Þ to obtain a censoring proportion around 25%. The longitudinal data are simulated from either a standard normal distribution or a ALD with the location parameter being b > X i ðtÞ þ u > i Z i ðtÞ and dispersion parameter being ¼ 1. We keep a maximum of six observations for each individual, at follow-up time t ¼ ð0, 0:25, 0:5, 0:75, 1, 3Þ respectively, after incorporating the time-to-event information.
We consider the following three scenarios: In each scenario, we simulate 200 datasets with N ¼ 600 in each. We then randomly select 500 individuals as the training data to build the model and use the remaining 100 individuals as the validation data to make out-ofsample predictions. For each simulated dataset, three MCMC chains are initiated with diverse starting values and the convergence of the chains is designated when the potential scale reduction factors (PSRF) 24 is less than 1.1 for all parameters. It takes approximately 30 min to complete the simulation with one dataset. With parallel computing, the total amount of time used for completing the whole simulation studies can be greatly reduced.
We report bias, standard error (SE), mean squared error (MSE), and coverage probability (CP) from the QRJM and LMJM. Table 1 (left panel) suggests that in Scenario 1, the true model (QRJM with ¼ 0:25) provides parameter estimates with very small biases and CP being close to the nominal level. For completeness, we also consider a scenario where the datasets are simulated from QRJM with ¼ 0:75 (left-skewed). Table 1 (right panel) suggests that the true model (QRJM with ¼ 0:75) has good performance in parameter estimation. In Scenario 2 (see Web Table S1 ) when data are symmetrical about 0 with heavier tails than the normal distribution, the LMJM still produces notably larger bias and lower CP as compared with the true model QRJM with ¼ 0:5. In Scenario 3 (see Web Table S2 ), median regression (the QRJM with ¼ 0:5) performs comparably to the true model LMJM, suggesting that the QRJM can provide reasonable estimates even when the random errors follow a standard normal distribution.
Simulation Study II: predictive performance
In this simulation study, we make predictions for 100 individuals in the validation dataset (out-of-sample predictions) in the three scenarios in Section 3.1. For each individual, we use the simulated data, random effects and the true parameter values to calculate the true survival probability given by S i ½sjM i ðs, u i , hÞ;h S i ½tjM i ðt, u i , hÞ;h and we use it as the ''gold standard''.
To assess the prediction calibration, we calculate the MSE of the predicted survival probabilities against the true simulated probabilities. Time-dependent AUC is also calculated for both gold standard survival probabilities (true AUC) as well as the model predictions (predicted AUC) as a measure of model discrimination ability. To make the predictions ''dynamic'', we choose different combinations of censoring time (i.e. t) and the prediction time interval (i.e. Át) to mimic expected real-world time points based on our HD dataset. Table 2 summarizes the MSE as well as the time-dependent AUC for three chosen censoring time points (t ¼ 0:25, 0:5, 0:75) in Scenario 1. For all combinations of ðt, ÁtÞ, the true QRJM with ¼ 0:25 provides accurate estimates of p i ðsjtÞ with negligible MSEs and the estimated AUCs being close to the true AUCs. In comparison, QRJM with ¼ 0:5 (i.e. median regression model) produces larger MSEs but comparable discrimination (i.e. the estimated AUCs being close to the true AUCs). The comparable discrimination should not be surprising because the regression parameters (except the intercept) are assumed to be independent of . In real data application, the covariate effects may differ at different percentiles and thus the AUCs may differ. Among the three models, LMJM had the worst performance in both calibration and discrimination.
Bland-Altman plot, 25 a commonly used method to assess the agreement of two measurement methods, is applied to visually compare the predicted results against the true values. Web Figure S2 gives an intuitive comparison of the predicted results with the ''gold standard'' among different models. Plots from the true model (Web Figure S2 .1) are horizontally spindle-shaped, suggesting that it is easier to predict a survival probability near 0 or 1 than the middle probability area near 0.5. Further, with an increase in Át, there is more variation in the middle probability area, indicating that survival probability predictions for time points further into the future are less accurate than predictions for closer time points, as expected. Bland-Altman plots from the other models (QRJM with ¼ 0:5, Web Figure S2 .2 and LMJM, Web Figure S2. 3) display systematically biased patterns in predictions, which are consistent with the findings in Table 2 . Simulation results for Scenario 3 are displayed in Web Table S3 and Web Figure S3 , in which QRJM with ¼ 0:5 performs comparably well as the LMJM (true model) when random errors are generated from standard normal distribution, suggesting the robustness of median regression model. In summary, when data are simulated from ALD with specific skewness , the QRJM with the exact quantile that generates the outcome data provides good estimation results and the best predictions of survival probability. When random errors are normally distributed, parameter estimates and risk predictions from QRJM with ¼ 0:5 are comparable with those from the true LMJM. In comparison, the LMJM results in systematically biased predictions when data are skewed and/or heavy-tailed.
Application 4.1 The Predictors of Huntington's Disease Study
The motivating Predictors of Huntington's Disease (PREDICT-HD) study is an observational study that aims to identify the earliest signs of HD onset so that future HD drug trials can be targeted toward treatment that may slow the progression of the disease, or prevent it altogether. 26 Briefly, HD is known to be caused by the mutation of the first exon of the Huntington (HTT) gene, where expansion of the cytosine-adenine-guanine (CAG) is observed for HD patients.
The study recruited individuals from 33 medical centers in six countries (i.e. USA, Canada, Germany, Australia, Spain, and UK) starting from August 2002. Qualified individuals were healthy pre-HD people without any symptoms of HD, i.e. who have not had a motor diagnosis of HD based on the Unified Huntington Disease Rating Scale (UHDRS) and had more than 35 HTT CAG repeats. Detailed inclusion and exclusion criteria can be found in Paulsen et al. 27 Baseline demographic information such as age, gender, education years, as well as clinical variables such as CAG repeat length and Beck Depression Inventory were recorded at enrollment. The data used in the current study contains 1078 individuals enrolled until July 2014. Among those 1078 individuals, 64% are female and the mean age at baseline is 39.8 years (SD ¼ 10.39, range 18.1-83.7), education is 14.5 years (SD ¼ 2.60, range 8.0-20.0), and number of CAG repeats is 42.5 (SD ¼ 2.69, range 12-62). In this study, the time variable is defined as months since enrollment. The average follow-up time is 61.2 months (SD ¼ 39.6; range 0.12-144.0) and 959 (89%) individuals have data for at least two years. The survival event of interest is time to motor diagnosis of HD since enrollment, which is defined as having a diagnostic confidence level (DCL) score of 4 (the highest score). 28 During the study follow-up, 225 (21%) events (HD onsets) were observed. We use total motor score (TMS) as the longitudinal outcome and consider the following QRJM for data analysis
where y i ðtÞ represents the observed TMS score of individual i at visit time t and age i is the baseline age. In the survival sub-model, we specify a piecewise constant baseline hazard function with three time intervals, i.e. 0 ðtÞ ¼ P 3 k¼1 k I k ðT i Þ, where t 1 ¼ 0, t 4 ¼ 144:0 (maximum event time in the data), t 2 and t 3 are the 1/3 and 2/3 quantiles of the event time, respectively. k is the hazard rate for time interval ½t k , t kþ1 Þ and I k ðtÞ ¼ 1 if t 2 ½t k , t kþ1 Þ and 0 otherwise. In addition to three intervals, we explored various numbers of pieces for the baseline hazard function and obtained very similar results (not shown). Table 3 presents the inference results from the QRJMs with TMS as the longitudinal biomarker at ¼ 0:25, 0.50, and 0.75. In the longitudinal process, the coefficient for time quantifies the change rate of TMS at a fixed quantile. For example, Table 3 suggests that the time effect is 0.019 (95% CI: 0.015, 0.023) for TMS at ¼ 0:25, indicating one month increase in time is associated with 0.019 unit increase of 25% conditional quantile of TMS. The positive time coefficients for TMS at all quantiles indicate that TMS increases (deteriorates) over time, which is consistent with the loess curve in Figure 1 (upper panel) . The magnitude of the time coefficients is similar at different quantiles of TMS, indicating comparable progression at those quantiles.
Inference results for PREDICT-HD data
Table 3 also suggests that higher baseline age is associated with higher (worse) TMS and one year increase in baseline age is associated with 0.004 (95% CI: 0.001, 0.008) units increase in TMS at ¼ 0:25. In the time to HD onset process, across all three quantiles, education has protective effect on HD onset, i.e. those with more education years tend to have a lower risk of HD onset. Outcome TMS is strongly predictive of HD onset at all quantiles. Specifically, a unit increase in TMS first quartile, median, and third quartile increases the risk of HD by 4.600 (expð1:526Þ, 95% CI 3.747-5.726), 3.669 (95% CI 3.152-4.302), and 2.945 (95% CI 2.633-3.294) times, respectively. These results suggest that when all other factors are fixed, a unit change in the first conditional quartile of TMS has the strongest effect on the hazard of HD onset, while a unit change in the third quartile has the smallest effect among the three quantiles considered here. The large positive significant estimates of the association parameter under all three quantiles suggest that for two individuals who have the same baseline covariates (i.e. education year and gender in our model), the one with higher TMS tends to have higher risk of developing HD.
Dynamic prediction of HD risk
Finally, to evaluate the predictive accuracy of the model, we randomly split the 1078 study individuals into five subgroups with approximately equal sizes and conduct five-fold cross validation. Each of the five subgroups will be used as the validation data once to make out-of-sample predictions based on the inference results from the data with the validation samples left out. In each model fitting step, two chains are initiated with diverse initial values and the chains are considered to converge if the PSRF for all parameters are below 1.1.
In the prediction step, we choose different censoring time (t) and prediction time window (Át) combinations. Predicted survival probabilities for all individuals are combined and used in the calculation of time-dependent AUC. There are several interesting ''patterns'' observed in Table 4 . First, compared with the LMJM, the QRJM has better prediction at some quantiles, but not all, because some quantiles of the outcome can be more informative in predicting future survival outcome than the conditional mean while some are not. There are also few cases where the QRJM has better predictions at all quantiles (e.g. t ¼ 12 at all Át) and vice versa (e.g. t ¼ 24, Át ¼ 12). Second, for a fixed censoring time t, time-dependent AUC usually decreases with increasing Át because long-term prediction is usually more difficult than short-term prediction). However, with excessive long follow-up time and large prediction interval (e.g. t ¼ 24 and 48, Át ¼ 36), most patients have low event-free probabilities and hence it is more difficult to differentiate them, leading to decreasing AUC. Third, with increased follow-up time t (i.e. t ¼ 12 vs. 24 vs. 48), the predictive performance generally improves (i.e. higher AUC) for the same prediction time window Át because longer follow-up time leads to additional observations thus more informative longitudinal data for prediction. However, exception is observed for the t ¼ 48 and Át ¼ 36 combination, whose AUCs are smaller than those from smaller t 0 s. The reason is that at the late follow-up time of 48 months, the number of individuals who remain HD free is relatively small and they are generally healthy. It becomes more difficult for the QRJM to differentiate those individuals in terms of disease-free probability.
In addition, we select three individuals (with IDs 12, 63, and 110) with different TMS trajectories (Figure 2(a) ) to illustrate how our method provides subject-specific dynamic predictions of HD-free survival. For each individual, predictions are calculated and then updated based on an increasing number of longitudinal measurements using QRJM at ¼ 0:25, 0:5, and 0.75, respectively. In Figure (2(b) ), we have the longitudinal measures up to 24 months (t ¼ 24) for each individual, and predictions are made for Át being 12, 24, 36, and 48 months, respectively. We then increase the follow-up time to 36 and 48 months (t ¼ 36 and t ¼ 48) and update the predictions using the same Át values. Updated prediction results are displayed in Figure (2(c) ) (t ¼ 36) and Figure (2(d)) (t ¼ 48) , respectively. The plots suggest that individuals with lower (better) and stable TMS have much higher HD-free probability (i.e. lower predicted risk of HD onset, individual 12 vs. individual 62 and 110). With longer follow-up times and more longitudinal measurements, predicted HD-free probabilities tend to be more accurate as indicated by narrower point-wise 95% credible intervals (t ¼ 48 months vs. t ¼ 24 months, not shown in plots). Comparing predictions from three different quantiles for the same individual, QRJM with higher predicts larger HD-free probabilities than lower for the same t and Át combination. This is consistent with the inference results presented in Table 3 , which suggest that the same amount change in lower conditional quantile has stronger impact on the hazard.
Discussion
In our application of the linear-mixed joint model (LMJM, a linear mixed sub-model for the longitudinal process and a Cox sub-model for the survival process) to Huntington's Disease (HD) using the PREDICT-HD study, there are two limitations. First, the normality assumption of the random errors in the linear mixed model (LMM) was not realistic (as shown in Figure 1 top panel) , and no obvious transformation of the longitudinal outcome to produce residual normality was applicable. Second, the LMJM only models the conditional mean of the outcome. However, in our (and other) clinical research application(s), it may be clinically more relevant to consider the tails of the outcome distribution, e.g. the upper tail of total motor score (TMS) is at higher risk of developing HD (as shown in the bottom panel of Figure 1 ).
Our proposed quantile regression joint models (QRJM) uses a linear quantile mixed model (LQMM) for the longitudinal process, and it improves both inference and the ability to make accurate dynamic predictions. The quantile-based estimators are more robust against skewness in the data. Thus, our approach provides the flexibility to use median or quantile regression instead of mean regression when outliers and skewness are present in the longitudinal process. Moreover, the QRJM provides quantile-specific parameter estimates at a set of different quantiles and the researchers can choose the quantiles of interest and the corresponding inference results. The simulation studies and data application suggest that the QRJM not only inherits the good properties of an LMJM, but adds flexibility to the modeling procedure. In practice, when the focus is on survival probability with a longitudinal process measured with error, Farcomeni and Viviani 12 suggested to select a single quantile . The selection of may depend on the scientific meaning and clinical relevance of the survival and longitudinal variables. In the motivating PREDICT-HD study, because a higher TMS indicates worse body motion abilities and it is associated with higher risk of HD onset, a large quantile (e.g. 0.75, 0.95) may be selected. Moreover, several quantiles from one tail may be used and the predictive results from them may be combined into a single prediction measure using valid methods such as Bayesian model averaging. 19 In this work, we develop a Bayesian algorithm to fit the proposed QRJM model and make dynamic predictions using the location-scale representation of the ALD for the longitudinal quantile regression. The Bayesian algorithm, which is straightforwardly implemented in JAGS software, uses a piecewise constant baseline hazard function in the survival sub-model. However, other functional forms can also be considered and the integration of the hazard function can be approximated using numerical integration such as Simpson's rule. In the real data application, we illustrate the flexibility of the QRJM and its advantages over the LMJM by jointly modeling the Table 4 . PREDICT-HD data analysis: time-dependent AUC of the predictions of HD-free probability from QRJM and LMJM with TMS as the longitudinal biomarker. risk of developing HD and total motor score (TMS, a commonly used early predictor of HD). The QRJM is able to provide more insight into the disease progression and the association between the two disease processes in terms of various quantile-based estimations and dynamic predictions. The novel application of our proposed QRJM in making personalized dynamic predictions of survival probability finds practical importance in many clinical applications. Event prediction using commonly collected biomarkers can provide clinicians with continuously updated ''disease progression'' information potentially allowing them to make appropriately timed intervention decisions for each individual. Subject-specific dynamic predictions models play an important role in the ongoing transformation of traditional medicine to personalized care. While in traditional medicine, treatment selection is guided by population-based experience, i.e. the average treatment effect in the entire population, such ''one-size-fits-all'' approaches are criticized for resulting in low efficacy and high adverse drug reactions in many clinical studies. Utilizing the dynamic predictions based on the proposed QRJM framework, we obtain subject-specific predictions of event risk that would actually allow physicians to tailor medical treatment based on a specific patient profile. In summary, the QRJM is a good alternative to the LMJM when either the normality assumption of the errors term is concerned or the conditional quantiles are more relevant to the research questions. The application of QRJM can certainly be extended by considering different and more complex functional forms for both outcomes to fit different scenarios, which can be an important direction for future research.
